Table 1 Demographic and clinical characteristics of participants
Characteristics | n=145 |
|---|---|
Adherence | |
No | 19 (13.1%) |
Yes | 126 (86.9%) |
Socio-demographics | |
Age in years, mean (SD) | 34.9±13.0 |
Age | |
<30 | 67 (46.2%) |
≥30 | 78 (53.8%) |
Income CDN ($) | |
≤34,999 | 30 (20.7%) |
≥35,000 | 104 (71.7%) |
Decline | 11 (7.6%) |
Education | |
High school or less | 14 (9.7%) |
University/college | 131 (90.3) |
Born in Canada | |
No | 39 (26.9%) |
Yes | 106 (73.1%) |
Years in Canada* | 23.1±18.4 |
Relationship status | |
Married/steady | 89 (61.4%) |
Single | 56 (38.6%) |
Smoking status | |
No | 121 (83.4%) |
Yes | 24 (16.6%) |
Medical characteristics | 16 (11.0%) |
Lesion severity (post-results) | |
Low-risk abnormalities | 83 (57.2%) |
High-risk abnormalities | 62 (42.8%) |
Previous history of colposcopy | |
No | 106 (73.1%) |
Yes | 38 (26.2) |
Unknown | 1 (0.7%) |
Sexually transmitted infections | |
None | 115 (79.3%) |
Chlamydia/herpes | 24 (16.5%) |
Other/unknown | 6 (4.2%) |
Contraception use | |
No | 50 (34.5%) |
Yes | 94 (64.8%) |
Condoms/OCP | 78 (83.0%) |
Other | 16 (17.0%) |
Video colposcopy** | Â |
No | 112 (89.0%) |
Yes | 25 (17.2%) |
Unknown | 8 (5.5%) |
Immunosuppression | |
No | 129 (89.0%) |
Yes | 16 (11.0%) |
HPV vaccine | |
No | 115 (79.3%) |
Yes | 28 (19.3%) |
Unknown | 1 (0.7%) |
Gardasil | 26 (96.3%) |